Código QR (código de barras bidimensional)

Erythrocyte-incorporated 6-mercaptopurine metabolite levels are not affected by recent drug administration during maintenance therapy for childhood acute lymphoblastic leukemia

Background: Childhood acute lymphoblastic leukemia (ALL) maintenance therapy with oral 6-mercaptopurine (6-MP) and methotrexate prevents leukemic relapse by acting against residual lymphoblasts. Non-adherence to oral maintenance therapy significantly increases ALL relapse risk. The levels of intrace...

תיאור מלא

שמור ב:
Principais autores: Lauryna Aukstikalne, Ignas Klejus, Maria Thastrup, Tadas Zvirblis, Kjeld Schmiegelow, Goda Elizabeta Vaitkeviciene, Linea Natalie Toksvang
פורמט: Artigo
שפה:Inglês
יצא לאור: Elsevier 2023-12-01
סדרה:EJC Paediatric Oncology
נושאים:
Leukemia
Acute
Lymphoblastic
Maintenance therapy
6-mercaptopurine
Relapse
גישה מקוונת:http://www.sciencedirect.com/science/article/pii/S2772610X23000260
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים